MAPT and neuroblastoma: Prompted by the encouraging in silico results, the biological effects were determined through in vitro studies of the main effectors in the antioxidant response on human neuroblastoma from the SH-SY5Y line and human embryonic kidney cells from the HEK293-tau line.